Product Images Spironolactone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Spironolactone NDC 51655-153 by Northwind Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 51655 153 26 Rev A 04 23

Label - 51655 153 26   Rev A 04 23

NDC: 51655-153-26 Rev. A 0423, Spironolactone Tablets USP of 100mg strength is available in a bottle of 90 tablets. These are prescription-only tablets and must be stored at a controlled room temperature of 20° - 25°C (68° - 77°F) to protect them from light. The tablets contain 100mg of spironolactone, an aldosterone receptor antagonist, and a potassium-sparing diuretic. Keep this medicine out of the reach of children and store it in the original container. The medicine is repackaged by Northwind Pharmaceuticals from Zydus Pharmaceuticals (USA) Inc. The lot number is 0000000000 and the expiration date is 00/00/0000. Please refer to the package insert for dosage and other instructions.*

Image - b9a028ee 5720 4b9e a625 f7130aafd084 01

Image - b9a028ee 5720 4b9e a625 f7130aafd084 01

Image - b9a028ee 5720 4b9e a625 f7130aafd084 02

Image - b9a028ee 5720 4b9e a625 f7130aafd084 02

This is a table comparing the outcomes of patients taking Spironolactone (n=822) versus placebo (n=841) over a period of 42 months. The table shows that the difference in the outcomes between the two groups was statistically significant (log-rank p value < 0.001). However, no specific details on those outcomes are provided.*

Image - b9a028ee 5720 4b9e a625 f7130aafd084 03

Image - b9a028ee 5720 4b9e a625 f7130aafd084 03

This appears to be a table of subgroup data related to heart failure patients, including age range, sex, race, heart failure severity, and medication usage. There is also data related to laboratory values such as serum creatinine and potassium. The table includes information on the number of patients in each subgroup and their corresponding values for various metrics. Finally, there is a note on the efficacy of Spironolactone compared to placebo.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.